We are live on ! Find out more

2,018 hedge funds and large institutions have $120B invested in Merck in 2018 Q2 according to their latest regulatory filings, with 120 funds opening new positions, 780 increasing their positions, 868 reducing their positions, and 77 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 120 | Existing positions closed: 77

37% more funds holding in top 10

Funds holding in top 10: 84115 (+31)

10% more call options, than puts

Call options by funds: $1.22B | Put options by funds: $1.1B

10% more capital invested

Capital invested by funds: $110B → $120B (+$10.7B)

1% more funds holding

Funds holding: 1,9932,018 (+25)

0.83% less ownership

Funds ownership: 78.21%77.38% (-0.83%)

10% less repeat investments, than reductions

Existing positions increased: 780 | Existing positions reduced: 868

Holders
2,018
Holders Change
+25
Holders Change %
+1.25%
% of All Funds
46.19%
Holding in Top 10
115
Holding in Top 10 Change
+31
Holding in Top 10 Change %
+36.9%
% of All Funds
2.63%
New
120
Increased
780
Reduced
868
Closed
77
Calls
$1.22B
Puts
$1.1B
Net Calls
+$112M
Net Calls Change
-$116M
Name Holding Trade Value Shares
Change
Change in
Stake
GI
601
GAMCO Investors
Connecticut
$6.27M -$267K -4,725 -4%
MCTIC
602
MacGuire Cheswick & Tuttle Investment Counsel
Connecticut
$6.24M +$185K +3,275 +3%
SFS
603
Strategic Financial Services
New York
$6.22M +$59.2K +1,050 +1%
SCI
604
SkyBridge Capital II
New York
$6.22M +$6.06M +107,371 New
RIA
605
RPG Investment Advisory
California
$6.18M +$25.5K +452 +0.4%
BIAS
606
Beacon Investment Advisory Services
New Jersey
$6.18M -$119K -2,102 -2%
SWM
607
Stockman Wealth Management
Montana
$6.17M -$281K -4,977 -4%
JAM
608
Jupiter Asset Management
United Kingdom
$6.15M -$564K -10,005 -9%
BG
609
Bollard Group
Massachusetts
$6.12M +$141K +2,500 +2%
CC
610
Capital Counsel
New York
$6.11M
LA
611
Lynch & Associates
Indiana
$6.11M +$480K +8,508 +9%
PCM
612
Parsons Capital Management
Rhode Island
$6.1M +$117K +2,074 +2%
TCOV
613
Trust Company of Vermont
Vermont
$6.09M +$147K +2,604 +3%
GCM
614
Gabalex Capital Management
New York
$6.07M
BIA
615
Barry Investment Advisors
Massachusetts
$6.07M +$202K +3,584 +4%
CB
616
Community Bank
New York
$6.07M -$34K -602 -0.6%
FFSOTS
617
Fiduciary Financial Services of The Southwest
Texas
$6.06M -$144K -2,550 -2%
DY
618
Dowling & Yahnke
California
$6.04M -$77.1K -1,367 -1%
GA
619
GFS Advisors
Texas
$6.03M +$60.6K +1,074 +1%
AAM
620
Augustine Asset Management
Florida
$6.01M +$94.5K +1,675 +2%
SSWM
621
Smith Salley Wealth Management
North Carolina
$6.01M +$168K +2,982 +3%
TAM
622
Tyers Asset Management
Texas
$5.99M +$1.54M +27,231 +36%
MDCM
623
Morgan Dempsey Capital Management
Wisconsin
$5.98M -$234K -4,152 -4%
OIM
624
Opus Investment Management
Massachusetts
$5.97M
ZCA
625
Zeke Capital Advisors
Pennsylvania
$5.94M +$666K +11,801 +13%

MRK Hedge Fund Activity: Q2 2018 in Review

2,018 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2018, worth a combined $120B — up 9.7% from $110B a quarter earlier.

Buyers outnumbered sellers: 120 funds opened new MRK positions and 77 closed out — a net gain of 43 holders — while 780 added to existing stakes and 868 trimmed.

The largest buyer was Capital World Investors, adding an estimated $904M. The largest seller was Dodge & Cox, cutting an estimated $620M.

  • 2,018 institutional investors held Merck (MRK) as of Q2 2018, up from 1,993 in Q1 2018.
  • Funds reported $120B of Merck stock for Q2 2018, up 9.7% quarter-over-quarter.
  • 120 funds opened new Merck positions in Q2 2018 and 77 closed out, a net change of +43 holders.
  • The largest Merck buyer in Q2 2018 was Capital World Investors, an estimated $904M added.
  • The largest Merck seller in Q2 2018 was Dodge & Cox, an estimated $620M sold.

Based on aggregated 13F filings for Q2 2018.